Hakutulokset - Marc Ferrante

Tarkenna hakua
  1. 1
    New biologics and small molecules in inflammatory bowel disease: an update

    New biologics and small molecules in inflammatory bowel disease: an update Tekijä João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD

    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD Tekijä Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    New treatment options for inflammatory bowel diseases

    New treatment options for inflammatory bowel diseases Tekijä Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? Tekijä Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Tekijä Konstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, Ann Gils, Adam S. Cheifetz

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors

    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors Tekijä Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease Tekijä Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis Tekijä Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns

    Julkaistu 2023
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease

    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease Tekijä Triana Lobatón, Marc Ferrante, P. Rutgeerts, Vera Ballet, Gert Van Assche, Séverine Vermeire

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?

    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? Tekijä Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet, Erwin Dreesen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis

    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis Tekijä Kaline Arnauts, Bram Verstockt, Anabela S. Ramalho, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding

    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Tekijä Sophie Restellini, Luc Biedermann, Petr Hrúz, Christian Mottet, Annick Moens, Marc Ferrante, Alain Schoepfer

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis Tekijä Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience Tekijä Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis

    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis Tekijä David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Séverine Vermeire, Paul Rutgeerts

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease Tekijä Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease

    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease Tekijä Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease

    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease Tekijä Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression Tekijä Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis

    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis Tekijä Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: